Russian Reports of Agreement to Produce Sputnik V in France Denied

Reading Time: < 1 minute

None of France’s pharmaceutical companies have signed a contract with Russia to produce its Sputnik V COVID-19 vaccine, a spokesman for France’s industry ministry said on Tuesday. The French reaction followed media reports by the head of Russia’s RDIF sovereign wealth fund stating an agreement had been sealed. Earlier, the head of RDIF said his organization had struck deals with production facilities in Italy, Spain, France and Germany to manufacture the Russian vaccine. “We have not identified a site which meets their requirements,” the French spokesperson added.

Source: Euractiv

CET Editor

Recent Posts

Teltonika drops EUR 3.5bn ‘dream’ project in Vilnius

Teltonika has announced it is halting the construction of its EUR 3.5bn High-Tech Hill park…

3 days ago

Hungary’s energy strategy has left it vulnerable to electricity price speculators – report

Hungary’s electricity market has become a focal point for speculative trading, driven by a combination…

3 days ago

CEE secures EUR 1.4bn in AI funding in 2023-24

Central and Eastern Europe (CEE) is a rising force in artificial intelligence (AI) and startups…

3 days ago

EU assesses candidates’ progress in ten country reports

The European Commission (EC) analyses the accession prospects of all ten prospective members of the…

3 days ago

CEE mulls ramifications of Trump’s victory on trade, defence, environment

As Donald Trump officially declared his victory in the US election, he received congratulations from…

1 week ago

‘Budapest Declaration’ signed as Orban hosts EU summit

European leaders committed to developing a defence industry base and enhancing EU competitiveness at an…

2 weeks ago